drugset / Trial / NCT00525135
Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
Phase 2
Terminated
5 enrolled
University of California, San Francisco
National Cancer Institute (NCI) · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs such as valproic acid may make thyroid cancers more radioiodine sensitive, which will allow for detection of tumor and make further ablation treatment effective.
Timeline
- Start
- 2007-08
- Primary completion
- 2009-03
- Completion
- 2009-03
Outcome
Outcome not reported
Stopped: “PI left university and study was halted prematurely. No data was analyzed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valproic Acid | Small molecule | — | — |